Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Marc Vogel, Patrick Köck, Johannes Strasser, Gerhard Wiesbeck, Marc Walter & Kenneth M. Dürsteler. (2019) Chronic High-Dose Buprenorphine Does Not Block Subjective High from Diacetylmorphine in a Patient in Heroin-Assisted Treatment. Journal of Psychoactive Drugs 51:4, pages 377-382.
Read now
Read now
Seyed Kaveh Hojjat, Seyed Esmaeil Hatami, Mahdi Rezaei, Mahin Hamidi & Mina Norozi Khalili. (2017) Women in opioid maintenance treatment in Iran: Background characteristics and history of substance use and risk behaviors. Journal of Substance Use 22:4, pages 377-383.
Read now
Read now
Dara Seybold, Byron Calhoun, Denise Burgess, Tammi Lewis, Kelly Gilbert & Angie Casto. (2014) Evaluation of a Training to Reduce Provider Bias Toward Pregnant Patients With Substance Abuse. Journal of Social Work Practice in the Addictions 14:3, pages 239-249.
Read now
Read now
Ingunn O Lund, Heather Fitzsimons, Michelle Tuten, Margaret S Chisolm, Kevin E O’Grady & Hendrée E Jones. (2012) Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes. Substance Abuse and Rehabilitation 3:sup1, pages 17-25.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now
Read now
DonaldR. Wesson & DavidE. Smith. (2010) Buprenorphine in the Treatment of Opiate Dependence. Journal of Psychoactive Drugs 42:2, pages 161-175.
Read now
Read now
Articles from other publishers (44)
Christine Bakos-Block, Angela J. Nash, A. Sarah Cohen & Tiffany Champagne-Langabeer. (2022) Experiences of Parents with Opioid Use Disorder during Their Attempts to Seek Treatment: A Qualitative Analysis. International Journal of Environmental Research and Public Health 19:24, pages 16660.
Crossref
Crossref
Olivia K. Golan, Rachel Totaram, Elizabeth Perry, Kennicia Fortson, Raul Rivera-Atilano, Rebecca Entress, Matthew Golan, Barbara Andraka-Christou, Daniel Whitaker & Therese Pigott. (2022) Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder. Drug and Alcohol Dependence 235, pages 109445.
Crossref
Crossref
Jennifer Langstengel & H. Klar Yaggi. (2022) Sleep Deficiency and Opioid Use Disorder. Clinics in Chest Medicine 43:2, pages e1-e14.
Crossref
Crossref
Lauren A. Walter, Savannah Bunnell, Kathryn Wiesendanger & Alyson J. McGregor. (2022) Sex, gender, and the opioid epidemic: Crucial implications for acute care. AEM Education and Training 6:S1.
Crossref
Crossref
Monica Rivera Mindt, Kelly Coulehan, Maral Aghvinian, Travis M. Scott, James Patrick Olsen, Chinazo O. Cunningham, Franchesca Arias & Julia H. Arnsten. (2022) Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment. Journal of Substance Abuse Treatment 135, pages 108644.
Crossref
Crossref
Zachary T. Glovak, Chelsea Angel, Christopher B. O’Brien, Helen A. Baghdoyan & Ralph Lydic. (2022) Buprenorphine differentially alters breathing among four congenic mouse lines as a function of dose, sex, and leptin status. Respiratory Physiology & Neurobiology 297, pages 103834.
Crossref
Crossref
Saeed Samarghandian, Shahnaz Rajabi, Michael Aschner, Vahid Noferesti & Tahereh Farkhondeh. (2022) Oxidative stress and apoptotic index modifications in the hippocampus of rat pups born to mothers exposed to buprenorphine during lactation. Toxicology Reports 9, pages 2050-2054.
Crossref
Crossref
Kala R. Crobarger. 2022. Clinical Pharmacology During Pregnancy. Clinical Pharmacology During Pregnancy
221
250
.
NL Michaels, HA Spiller, J Badeti, AH Sheftall, AR Funk & GA Smith. (2021) Benzodiazepine exposures among women of reproductive age in the US, 2004–2018. Human & Experimental Toxicology 40:11, pages 1807-1816.
Crossref
Crossref
Christopher Vierke, Brigitte Marxen, Michael Boettcher, Christoph Hiemke & Ursula Havemann-Reinecke. (2020) Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy. European Archives of Psychiatry and Clinical Neuroscience 271:5, pages 847-856.
Crossref
Crossref
Caitlin E. Martin, Anna Scialli & Mishka Terplan. 2021. How Sex and Gender Impact Clinical Practice. How Sex and Gender Impact Clinical Practice
23
51
.
Linda L.M. Worley & Alexandra Wise-Ehlers. (2020) Telepsychiatry in Obstetrics. Obstetrics and Gynecology Clinics of North America 47:2, pages 333-340.
Crossref
Crossref
Louise Geddes, Jenny Iversen, Handan Wand, Aryan Esmaeili, Judith Tsui, Margaret Hellard, Gregory Dore, Jason Grebely, Paul Dietze, Julie Bruneau, Maria Prins, Megan D Morris, Naglaa H Shoukry, Andrew R Lloyd, Arthur Y Kim, Georg Lauer, Andrea L Cox, Kimberly Page & Lisa Maher. (2020) Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection. Clinical Infectious Diseases 70:1, pages 123-131.
Crossref
Crossref
Alfred Shoukry & Melissa A. McNeil. 2020. Sex- and Gender-Based Women's Health. Sex- and Gender-Based Women's Health
485
493
.
Kimberly Mangla, M. Camille Hoffman, Caroline Trumpff, Sinclaire O’Grady & Catherine Monk. (2019) Maternal self-harm deaths: an unrecognized and preventable outcome. American Journal of Obstetrics and Gynecology 221:4, pages 295-303.
Crossref
Crossref
Whitney Peters, Connie Guille & Leena Mittal. 2019. Neurology and Psychiatry of Women. Neurology and Psychiatry of Women
103
113
.
Daniel I Rhon, Suzanne J Snodgrass, Joshua A Cleland, Charles D Sissel & Chad E Cook. (2018) Predictors of chronic prescription opioid use after orthopedic surgery: derivation of a clinical prediction rule.. Perioperative Medicine 7:1.
Crossref
Crossref
Alicia A. Jacobs & Michelle Cangiano. (2018) Medication-Assisted Treatment Considerations for Women with Opiate Addiction Disorders. Primary Care: Clinics in Office Practice 45:4, pages 731-742.
Crossref
Crossref
Emily L. Newman, Michael Z. Leonard, Danielle T. Arena, Rosa M.M. de Almeida & Klaus A. Miczek. (2018) Social defeat stress and escalation of cocaine and alcohol consumption: Focus on CRF. Neurobiology of Stress 9, pages 151-165.
Crossref
Crossref
Carolyn M Mazure & David A Fiellin. (2018) Women and opioids: something different is happening here. The Lancet 392:10141, pages 9-11.
Crossref
Crossref
Laura J. Faherty, Meredith Matone, Molly Passarella & Scott Lorch. (2018) Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure. Maternal and Child Health Journal 22:6, pages 841-848.
Crossref
Crossref
Lee Dresang, Randall Brown & Elizabeth J. Kvach. 2016. Office Care of Women. Office Care of Women
483
493
.
. 2016. Office Care of Women. Office Care of Women
367
544
.
Rebecca I. Hartman & Alexa B. Kimball. (2016) Performing research in pregnancy: Challenges and perspectives. Clinics in Dermatology 34:3, pages 410-415.
Crossref
Crossref
Stacey Gramann. 2016. Treating Comorbid Opioid Use Disorder in Chronic Pain. Treating Comorbid Opioid Use Disorder in Chronic Pain
89
101
.
Shana Harris. (2015) To Be Free and Normal: Addiction, Governance, and the Therapeutics of Buprenorphine. Medical Anthropology Quarterly 29:4, pages 512-530.
Crossref
Crossref
L. R. Lander, K. K. Gurka, P. J. Marshalek, M. Riffon & C. R. Sullivan. (2015) A Comparison of Pregnancy-Only versus Mixed-Gender Group Therapy among Pregnant Women with Opioid Use Disorder. Social Work Research 39:4, pages 235-244.
Crossref
Crossref
Laura Brandt, Anna K. Leifheit, Loretta P. Finnegan & Gabriele Fischer. 2014. Psychopharmacology and Pregnancy. Psychopharmacology and Pregnancy
169
195
.
Hisham Alhaddad, Salvatore Cisternino, Bruno Saubamea, Joel Schlatter, Fouad Chiadmi, Patricia Risède, Maria Smirnova, Véronique Cochois-Guégan, Nicolas Tournier, Frédéric J. Baud & Bruno Mégarbane. (2013) Gender and strain contributions to the variability of buprenorphine-related respiratory toxicity in mice. Toxicology 305, pages 99-108.
Crossref
Crossref
Rouhollah Qurishi, Christina Sonneborn, Marieke de Jong-Arts & Cornelis de Jong. (2013) Premenstrual Syndrome and Self-Medication With Opioids. Journal of Addiction Medicine 7:1, pages 79-82.
Crossref
Crossref
Flavia Franconi, Ilaria Campesi, Stefano Occhioni, Paola Antonini & Michael F. Murphy. 2012. Sex and Gender Differences in Pharmacology. Sex and Gender Differences in Pharmacology
107
126
.
Bernadette Winklbaur-Hausknost, Reinhold Jagsch, Klaudia Graf-Rohrmeister, Annemarie Unger, Andjela Baewert, Martin Langer, Kenneth Thau & Gabriele Fischer. (2013) Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women. Human Psychopharmacology: Clinical and Experimental 28:1, pages 15-24.
Crossref
Crossref
Hendrée E. Jones, Sarah H. Heil, Andjela Baewert, Amelia M. Arria, Karol Kaltenbach, Peter R. Martin, Mara G. Coyle, Peter Selby, Susan M. Stine & Gabriele Fischer. (2012) Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction 107, pages 5-27.
Crossref
Crossref
Eliza M. Park, Samantha Meltzer-Brody & Joji Suzuki. (2012) Evaluation and Management of Opioid Dependence in Pregnancy. Psychosomatics 53:5, pages 424-432.
Crossref
Crossref
Wim van den Brink. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology
235
261
.
Wim van den Brink. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology
214
234
.
A.S. Höflich, M. Langer, R. Jagsch, A. Bäwert, B. Winklbaur, G. Fischer & A. Unger. (2012) Peripartum pain management in opioid dependent women. European Journal of Pain 16:4, pages 574-584.
Crossref
Crossref
Verena Metz, Birgit Köchl & Gabriele Fischer. (2012) Should pregnant women with substance use disorders be managed differently?. Neuropsychiatry 2:1, pages 29-41.
Crossref
Crossref
Annemarie Unger, Verena Metz & Gabriele Fischer. (2012) Opioid Dependent and Pregnant: What Are the Best Options for Mothers and Neonates?. Obstetrics and Gynecology International 2012, pages 1-6.
Crossref
Crossref
Andrew C. Eschenroeder, Allison A. Vestal-Laborde, Emilse S. Sanchez, Susan E. Robinson & Carmen Sato-Bigbee. (2012) Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: Implications for drug addiction treatment during pregnancy. Glia 60:1, pages 125-136.
Crossref
Crossref
David E. Moody, Wenfang B. Fang, Jerdravee Morrison & Elinore McCance-Katz. (2011) Gender differences in pharmacokinetics of maintenance dosed buprenorphine. Drug and Alcohol Dependence 118:2-3, pages 479-483.
Crossref
Crossref
Sonja Brünen, Philippe D Vincent, Pierre Baumann, Christoph Hiemke & Ursula Havemann-Reinecke. (2011) Therapeutic Drug Monitoring for Drugs Used in the Treatment of Substance-Related Disorders: Literature Review Using a Therapeutic Drug Monitoring Appropriateness Rating Scale. Therapeutic Drug Monitoring 33:5, pages 561-572.
Crossref
Crossref
William A. Alto & Alane B. O'Connor. (2011) Management of women treated with buprenorphine during pregnancy. American Journal of Obstetrics and Gynecology 205:4, pages 302-308.
Crossref
Crossref
Verena Metz, Reinhold Jagsch, Nina Ebner, Johanna Würzl, Anna Pribasnig, Constantin Aschauer & Gabriele Fischer. (2011) Impact of treatment approach on maternal and neonatal outcome in pregnant opioid‐maintained women. Human Psychopharmacology: Clinical and Experimental 26:6, pages 412-421.
Crossref
Crossref